• Something wrong with this record ?

FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention

L. Zlatohlavek, M. Vrablik, E. Motykova, R. Ceska, L. Vasickova, D. Dlouha, JA. Hubacek,

. 2013 ; 46 (4-5) : 313-316.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NS10589 MZ0 CEP Register

OBJECTIVES: This study aimed to determine whether there is a relationship between common FTO (rs17817449) and MC4R (rs17782313) gene variants and body mass reduction or weight loss after a one-month lifestyle intervention in overweight/obese children. DESIGN AND METHODS: We genotyped 357 unrelated non-diabetic Czech children (age 13.7 ± 4.9 years, average BMI at baseline 30.8 ± 4.6 kg/m(2)). Biochemical and anthropometrical measurements were performed before and after 4 weeks of lifestyle interventions (comprising a reduction in energy intake to the age-matched optimum and a supervised exercise program consisting of 5 exercise units per day, 50 min each). RESULTS: The mean weight loss achieved was 6.2 ± 2.1 kg (P<0.001). Significant associations were found between a BMI decrease and the FTO and MC4R variants. Carriers of the FTO GG genotype and/or MC4R CC genotype lost significantly more body weight compared to noncarriers (P<0.0009 for BMI and P<0.002 for body weight). These differences remained significant following adjustment for sex, age and baseline values (P=0.004 for BMI and P=0.01 for body weight). CONCLUSIONS: FTO and MC4R gene variants modify the impact of an intensive lifestyle intervention on BMI decrease in overweight/obese children. Carriers of the FTO GG genotype and MC4R CC genotype benefit significantly more from the lifestyle intervention.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13031795
003      
CZ-PrNML
005      
20170411120537.0
007      
ta
008      
131002s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.clinbiochem.2012.11.017 $2 doi
035    __
$a (PubMed)23201545
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zlatohlavek, L $u 3rd Department of Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic. l.zlato@tiscali.cz
245    10
$a FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention / $c L. Zlatohlavek, M. Vrablik, E. Motykova, R. Ceska, L. Vasickova, D. Dlouha, JA. Hubacek,
520    9_
$a OBJECTIVES: This study aimed to determine whether there is a relationship between common FTO (rs17817449) and MC4R (rs17782313) gene variants and body mass reduction or weight loss after a one-month lifestyle intervention in overweight/obese children. DESIGN AND METHODS: We genotyped 357 unrelated non-diabetic Czech children (age 13.7 ± 4.9 years, average BMI at baseline 30.8 ± 4.6 kg/m(2)). Biochemical and anthropometrical measurements were performed before and after 4 weeks of lifestyle interventions (comprising a reduction in energy intake to the age-matched optimum and a supervised exercise program consisting of 5 exercise units per day, 50 min each). RESULTS: The mean weight loss achieved was 6.2 ± 2.1 kg (P<0.001). Significant associations were found between a BMI decrease and the FTO and MC4R variants. Carriers of the FTO GG genotype and/or MC4R CC genotype lost significantly more body weight compared to noncarriers (P<0.0009 for BMI and P<0.002 for body weight). These differences remained significant following adjustment for sex, age and baseline values (P=0.004 for BMI and P=0.01 for body weight). CONCLUSIONS: FTO and MC4R gene variants modify the impact of an intensive lifestyle intervention on BMI decrease in overweight/obese children. Carriers of the FTO GG genotype and MC4R CC genotype benefit significantly more from the lifestyle intervention.
650    _2
$a mladiství $7 D000293
650    _2
$a index tělesné hmotnosti $7 D015992
650    _2
$a dítě $7 D002648
650    _2
$a redukční dieta $7 D004038
650    _2
$a energetický příjem $7 D002149
650    _2
$a genetická epistáze $7 D004843
650    _2
$a terapie cvičením $7 D005081
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a frekvence genu $7 D005787
650    _2
$a genetické asociační studie $7 D056726
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a obezita $x genetika $x terapie $7 D009765
650    _2
$a nadváha $x genetika $x terapie $7 D050177
650    _2
$a polymorfismus genetický $7 D011110
650    _2
$a proteiny $x genetika $7 D011506
650    _2
$a receptor melanokortinový typ 4 $x genetika $7 D044105
650    _2
$a sekvenční analýza DNA $7 D017422
650    _2
$a programy na snížení hmotnosti $7 D061217
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vrablik, M $u -
700    1_
$a Tůmová, Eva $u - $7 xx0210915
700    1_
$a Ceska, R $u -
700    1_
$a Vasickova, L $u -
700    1_
$a Dlouha, D $u -
700    1_
$a Hubacek, J A $u -
773    0_
$w MED00001119 $t Clinical biochemistry $x 1873-2933 $g Roč. 46, č. 4-5 (2013), s. 313-316
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23201545 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20131002 $b ABA008
991    __
$a 20170411120836 $b ABA008
999    __
$a ok $b bmc $g 995882 $s 830240
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 46 $c 4-5 $d 313-316 $i 1873-2933 $m Clinical biochemistry $n Clin Biochem $x MED00001119
GRA    __
$a NS10589 $p MZ0
LZP    __
$a Pubmed-20131002

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...